E-LIB Suche - Ergebnisse für: Sven Borchmann

1

Human leukocyte antigen (HLA) class I expression on Hodgkin..:

Müller‐Meinhard, Berit ; Seifert, Nicole ; Grund, Johanna...
HemaSphere. 8 (2024) 6 - p. , 2024

2

Noninvasive minimal residual disease assessment in relapsed..:

Heger, Jan‐Michel ; d'Hargues, Yannick ; Kleinert, Fanni...
European Journal of Haematology. 112 (2024) 6 - p. 957-963 , 2024

Link: https://doi.org/10.1111/..

3

Blocking the angiopoietin-2–dependent integrin β-1 signalin..:

Meder, Lydia ; Orschel, Charlotte Isabelle ; Otto, Christoph Julius...
JCI Insight. 9 (2024) 10 - p. , 2024

Link: https://doi.org/10.1172/..

4

P1209: PERIPHERAL BLOOD CTDNA-SEQUENCING ENABLES PREDICTION..:

Heger, Jan-Michel ; Mattlener, Julia ; Gödel, Philipp...
HemaSphere. 7 (2023) S3 - p. e45690bd , 2023

Link: https://doi.org/10.1097/..

5

S236: HIGH-BREADTH SEQUENCING OF CIRCULATING TUMOR DNA IDEN..:

Heger, Jan-Michel ; Mattlener, Julia ; Mammadova, Laman...
HemaSphere. 7 (2023) S3 - p. e8618132 , 2023

Link: https://doi.org/10.1097/..

6

P1384: MULTI-EFFECTOR IMMUNE CELL RETARGETING USING A BISPE..:

Freihammer, Max ; Jayalath, Pramudini ; Shi, Zhiyuan...
HemaSphere. 7 (2023) S3 - p. e49676c6 , 2023

Link: https://doi.org/10.1097/..

7

Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymph..:

Drees, Esther E. E. ; Jauw, Yvonne W. S. ; van Dijk, Erik...
HemaSphere. 6 (2022) 7 - p. e749 , 2022

Link: https://doi.org/10.1097/..

8

P046: Preclinical evaluation of novel repurposed drug combi..:

Lohmann, Mia ; Buchberger, Iris ; Beielstein, Anna...
HemaSphere. 6 (2022) - p. 21-21 , 2022

Link: https://doi.org/10.1097/..

9

P059: Multi-effector cell targeting with half-life extended..:

Shi, Zhiyuan ; Kern, Verena ; Freihammer, Max..
HemaSphere. 6 (2022) - p. 27-27 , 2022

Link: https://doi.org/10.1097/..

10

EGFR Inhibition Strongly Modulates the Tumour Immune Microe..:

Selenz, Carolin ; Compes, Anik ; Nill, Marieke...
Cancers. 14 (2022) 16 - p. 3943 , 2022

Link: https://doi.org/10.3390/..

11

JAK inhibition with ruxolitinib in relapsed or refractory c..:

Gillessen, Sarah ; Pluetschow, Annette ; Vucinic, Vladan...
European Journal of Haematology. 109 (2022) 6 - p. 728-735 , 2022

Link: https://doi.org/10.1111/..

12

Controversies in the Interpretation of Liquid Biopsy Data i..:

Pirosa, Maria Cristina ; Borchmann, Sven ; Jardin, Fabrice..
HemaSphere. 6 (2022) 6 - p. e727 , 2022

Link: https://doi.org/10.1097/..

13

Tripartite antigen-agnostic combination immunotherapy cures..:

Borchmann, Sven ; Selenz, Carolin ; Lohmann, Mia...
Journal for ImmunoTherapy of Cancer. 10 (2022) 10 - p. e004781 , 2022

Link: https://doi.org/10.1136/..

14

P037: High breadth whole exome sequencing of circulating tu..:

Mammadova, Laman ; Heger, Jan-Michel ; Mattlener, Julia...
HemaSphere. 6 (2022) - p. 17-18 , 2022

Link: https://doi.org/10.1097/..

15

MAPK-pathway inhibition mediates inflammatory reprogramming..:

Brägelmann, Johannes ; Lorenz, Carina ; Borchmann, Sven...
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..